APA (7th ed.) Citation

Lipton, R., Campos, V. R., Arie, Z. R., Krasenbaum, L., Ning, X., Galic, M., & Marmura, M. (2023). Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: Results from the UNITE study. Journal of the Neurological Sciences, 455, N.PAG. https://doi.org/10.1016/j.jns.2023.121112

Chicago Style (17th ed.) Citation

Lipton, Richard, Verena Ramirez Campos, Zipora Roth-Ben Arie, Lynda Krasenbaum, Xiaoping Ning, Maja Galic, and Michael Marmura. "Efficacy of Fremanezumab Treatment in Reducing Monthly Migraine Days in Patients with Migraine and Major Depressive Disorder: Results from the UNITE Study." Journal of the Neurological Sciences 455 (2023): N.PAG. https://doi.org/10.1016/j.jns.2023.121112.

MLA (9th ed.) Citation

Lipton, Richard, et al. "Efficacy of Fremanezumab Treatment in Reducing Monthly Migraine Days in Patients with Migraine and Major Depressive Disorder: Results from the UNITE Study." Journal of the Neurological Sciences, vol. 455, 2023, p. N.PAG, https://doi.org/10.1016/j.jns.2023.121112.